Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (271-280 of 740) with videos related to

Pageof 74
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Natural history of osteonecrosis of the jaw in patients with multiple myelomaAshraf Badros, Evangelos Terpos, Eirini Katodritou, et al.
Expert Review of Hematology|September 29, 2025
Current experiences with teclistamab in patients with multiple myeloma and renal impairmentMeletios A Dimopoulos, Yael C Cohen, Aurore Perrot, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2011
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myelomaMaria Gkotzamanidou, Efstathios Kastritis, Maria Roussou Magdalini Migkou Maria Gavriatopoulou, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 6, 2015
Early tumor-cell gene expression changes may predict the response to first-line bortezomib-based therapy in patients with newly diagnosed multiple myelomaKonstantinos Liapis, Efstathios Kastritis, Tina Bagratouni, et al.
Genome Medicine|July 25, 2022
Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritisMarietta Armaka, Dimitris Konstantopoulos, Christos Tzaferis, et al.
Blood Cancer Journal|May 12, 2018
Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myelomaEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Dimitrios Christoulas, et al.
Gynecologic Oncology|June 8, 2002
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology GroupMeletios A Dimopoulos, Christos A Papadimitriou, Kyrillos Sarris, et al.
Frontiers in Cardiovascular Medicine|March 18, 2021
Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or EverolimusChristos Papageorgiou, Flora Zagouri, Konstantinos Tampakis, et al.
European Journal of Haematology|June 3, 2011
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapyMagdalini Migkou, Efstathios Kastritis, Maria Roussou, et al.
Clinical Nephrology|November 21, 2015
Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsyEvangelia Charitaki, Efstathios Kastritis, Constantina Petraki, et al.
Pageof 74

Showing results (271-280 of 740) with videos related to

Sort By:
Pageof 74
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Natural history of osteonecrosis of the jaw in patients with multiple myelomaAshraf Badros, Evangelos Terpos, Eirini Katodritou, et al.
Expert Review of Hematology|September 29, 2025
Current experiences with teclistamab in patients with multiple myeloma and renal impairmentMeletios A Dimopoulos, Yael C Cohen, Aurore Perrot, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2011
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myelomaMaria Gkotzamanidou, Efstathios Kastritis, Maria Roussou Magdalini Migkou Maria Gavriatopoulou, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 6, 2015
Early tumor-cell gene expression changes may predict the response to first-line bortezomib-based therapy in patients with newly diagnosed multiple myelomaKonstantinos Liapis, Efstathios Kastritis, Tina Bagratouni, et al.
Genome Medicine|July 25, 2022
Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritisMarietta Armaka, Dimitris Konstantopoulos, Christos Tzaferis, et al.
Blood Cancer Journal|May 12, 2018
Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myelomaEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Dimitrios Christoulas, et al.
Gynecologic Oncology|June 8, 2002
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology GroupMeletios A Dimopoulos, Christos A Papadimitriou, Kyrillos Sarris, et al.
Frontiers in Cardiovascular Medicine|March 18, 2021
Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or EverolimusChristos Papageorgiou, Flora Zagouri, Konstantinos Tampakis, et al.
European Journal of Haematology|June 3, 2011
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapyMagdalini Migkou, Efstathios Kastritis, Maria Roussou, et al.
Clinical Nephrology|November 21, 2015
Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsyEvangelia Charitaki, Efstathios Kastritis, Constantina Petraki, et al.
Pageof 74